Evonik confirms independence from BASF merger discussions while reporting a reduced Q3 net loss of €53 million. The company maintains full-year EBITDA guidance alongside ongoing asset sales. M&A activity in the specialty chemicals sector remains active, though consolidation faces resistance from management prioritizing autonomy. Market sentiment may stabilize given improved operational performance. Maintaining independence allows Evonik to pursue its own strategic priorities without integration risks. Narrowing losses and steady EBITDA suggest improving fundamentals despite external acquisition pressure.
11 articles
Evonik reaffirmed its independent strategy despite BASF merger interest, reported a narrowed Q3 net loss of €53 million, and maintained full-year EBITDA guidance while advancing asset sales.
ICIS Europe highlights acrylate ester duties, bullish ethanol markets, and BASF-Evonik M&A talks alongside fertilizer shortfalls threatening food security. Key petrochemical trends include polyethylen
BASF has reportedly raised its acquisition offer for Evonik Industries to €11.2 billion, promising to preserve regional jobs until 2032 and optimize raw material sourcing to improve cost competitivene
BASF CEO Markus Kamieth confirmed readiness to discuss a merger with Evonik Industries, emphasizing value creation without compromising shareholder interests. The proposed combination aims to strength
BASF has indicated it will maintain Evonik's German employment guarantees until 2032 in any potential takeover agreement. This commitment addresses political and union concerns following Evonik's reje
Evonik Industries rejected a €10.3 billion acquisition offer from BASF, signaling a major shift in the chemical sector. The report also covers a new amino acids joint venture between CJ CheilJedang an
ICIS Europe's weekly roundup covers rising polyethylene margins, Evonik rejecting BASF's €10.3 billion takeover bid, and logistical disruptions from low Rhine water levels affecting chemical trade.
The CW75 index fell 0.98% for the week ending Sept. 29, outperforming broader markets, while Evonik shares surged following reports of a €10.3 billion acquisition bid from BASF.
Experts discuss how a potential BASF and Evonik merger could establish an integrated regional leader to compete in the oversupplied global chemical market. Consolidation is highlighted as vital for Eu
Evonik Industries rejected BASF's €10.3 billion non-binding takeover offer, stating it was too low for formal talks. Consequently, Evonik's share price surged over 10% while BASF's dipped amidst marke
Evonik rejected BASF's €10.3 billion takeover bid, stating it was too low for formal negotiations or due diligence, per Financial Times reports.
ChemBrief